KARYOPHARM THERAPEUTICS INC.
Exhibit 10.9
KARYOPHARM THERAPEUTICS INC.
May 29, 2013
Paul Brannelly
Dear Paul:
On behalf of Karyopharm Therapeutics Inc., (the Company), I am very pleased to offer you the position of Senior Vice President, Finance & Administration, of the Company.
The terms of your position with the Company are as set forth below:
1. Position. On the Commencement Date, as defined in Section 2, you will become the Senior Vice President, Finance & Administration, of the Company. You will serve as Senior Vice President, Finance & Administration, reporting to the Companys Chief Executive Officer (CEO). In your role, you will have the responsibilities customarily associated with such position and those that are assigned to you by the Companys CEO. During the term of your employment with the Company, you will devote your full professional time and efforts to the business of the Company.
2. Commencement Date. You will commence your new position with the Company, effective on Monday, June 3, 2013 (the Commencement Date).
3. Compensation.
a. Base Salary. You will be paid an annualized base salary of Two Hundred Seventy-Five Thousand Dollars ($275,000), subject to tax and other withholdings required by law. Your base salary will be payable pursuant to the Companys regular payroll policy. Your salary may be adjusted from time to time in accordance with normal business practices and in the sole discretion of the Company.
b. Bonus Program. You will be eligible for an annual bonus (commencing with a pro-rated bonus for 2013 based on your start date) that targets twenty-five percent (25%) of your annualized base salary based upon achievement of certain performance goals and corporate milestones established by the Company. Achievement of goals will be determined in the sole discretion of the Board of Directors of the Company (the Board) or a Compensation Committee of the Board. To earn any part of the bonus, you must be employed on December 31st of the applicable bonus year.
c. Option Grant. As soon as practicable after the Commencement Date, subject to Board approval, the Company will grant to you a non-qualified stock option for the purchase of 210,000 shares of the Companys Common Stock, $.0001 par value per share (the Common Stock) at a purchase price per share equal to the fair market value per share of Common Stock at the time of Board approval, as determined by the Board in its sole discretion (the Option). The Option shall vest as follows: 25% of the shares underlying the Option to vest on the first anniversary of the Commencement Date and an
additional 2.0833% of the shares to vest each month thereafter over the following thirty-six (36) months.
Notwithstanding the vesting schedule set forth above, subject to Board approval, you will have the right to exercise the Option as to the unvested portion of the Option (in addition to the vested portion) if simultaneously with such exercise, you enter into a Restricted Stock Agreement provided to you by the Company (the Restricted Stock Agreement). The Restricted Stock Agreement will provide that the shares issued to you pursuant to your exercise of any unvested portion of the Option shall be subject to a right of repurchase (the Purchase Option) in favor of the Company in the event that you cease to provide services to the Company, such Purchase Option to lapse in accordance with the vesting schedule of the Option.
The Option, including, but not limited to the foregoing vesting provisions and early exercise right, will be subject to the terms of the Companys standard form of non-qualified stock option agreement and the Companys 2010 Stock Incentive Plan.
d. Withholding. The Company shall withhold from any compensation or benefits payable under this letter agreement any federal, state and local income, employment or other similar taxes as may be required to be withheld pursuant to any applicable law or regulation.
4. Benefits.
a. Vacation and Holidays. You will be eligible for a maximum of 15 days of paid vacation each year and Company paid holidays consistent with the Companys vacation policy (including accrual of vacation days).
b. Other. You will be eligible to participate in such medical, retirement and other benefits as are approved by the Board and made available to other employees of the Company.
As is the case with all employee benefits, such benefits will be governed by the terms and conditions of applicable plans or policies, which are subject to change or discontinuation at any time.
5. At-Will Employment. Your employment with the Company is and shall at all times during your employment hereunder be at-will employment. The Company or you may terminate your employment at any time for any reason, with or without cause, and with or without notice. The at-will nature of your employment shall remain unchanged during your tenure as an employee of the Company, and may only be changed by an express written agreement that is signed by you and the Company.
6. Employee Confidentiality Agreement. As an employee of the Company, you will have access to certain Company and third party confidential information and you may during the course of your employment develop certain information or inventions which will be the property of the Company. To protect the interest of the Company you agree to sign the Companys standard
Non-Disclosure and Inventions Assignment Agreement as a condition of your employment, a copy of which has been provided.
7. Resolution of Disputes. Any controversy or claim arising out of or relating to your employment, this letter agreement, its enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, shall be submitted to arbitration in Boston, Massachusetts before a single arbitrator (applying Massachusetts law), in accordance with the National Rules for the Resolution of Employment Disputes then in effect of the American Arbitration Association (AAA) as modified by the terms and conditions of this Section 7; provided, however, that provisional injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally determined by the arbitrator. The arbitrator shall be selected by mutual agreement of the parties or, if the parties cannot agree, by striking from a list of arbitrators supplied by AAA. The arbitrator shall issue a written opinion revealing, however briefly, the essential findings and conclusions upon which any award is based. Final resolution of any dispute through arbitration may include any remedy or relief which the arbitrator deems just and equitable. Any award or relief granted by the arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.
The parties acknowledge that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with this letter agreement or your employment.
The arbitrator shall have the sole and exclusive power and authority to decide any and all issues of or related to whether this letter agreement or any provision of this letter agreement is subject to arbitration.
8. No Inconsistent Obligations. By accepting this offer of employment, you represent and warrant to the Company that you are under no obligations or commitments, whether contractual or otherwise, that are inconsistent with your obligations set forth in this letter agreement or that would be violated by your employment by the Company. You agree that you will not take any action on behalf of the Company or cause the Company to take any action that will violate any agreement that you have with a prior employer.
9. Miscellaneous.
a. This letter agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.
b. The Company may only assign this letter agreement to a successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, provided, that such successor expressly agrees to assume and perform this letter agreement in the same manner and to the same
extent that the Company would have been required to perform it if no such assignment had taken place, and Company shall include any such successor that assumes and agrees to perform this letter agreement, by operation of law or otherwise.
c. No provision of this letter agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by you and the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this letter agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
10. The validity, interpretation, construction and performance of this letter agreement shall be governed by the laws of the Commonwealth of Massachusetts without regard to the choice of law principles thereof.
I look forward to your joining the Company to create a successful company, and I am confident that your employment with the Company will prove mutually beneficial. If you have any further questions or require additional information, please feel free to contact me.
If you do not accept this offer by signing below and returning the signed letter to me by June 5, 2013, this offer will be revoked.
[Signatures appear on following page]
| Sincerely, | ||||
|
| ||||
|
| ||||
| KARYOPHARM THERAPEUTICS INC. | ||||
|
| ||||
|
|
| |||
| By: | /s/ Michael Kauffman | |||
|
| Michael Kauffman | |||
|
| Chief Executive Officer | |||
|
| ||||
I hereby agree to the foregoing |
| ||||
terms of employment: |
| ||||
|
|
| |||
Agreed: | /s/ Paul Brannelly |
|
| ||
| Paul Brannelly |
| |||
|
| ||||
Date: | May 31, 2013 |
|
| ||
Attachment: Non-Disclosure and Inventions Assignment Agreement